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ABSTRACT
Objectives: The impact of surface disinfection versus
detergent cleaning on healthcare associated infection
rates remains unresolved. We aimed to evaluate the
efficacy of hydrogen peroxide (HP) decontamination
against methicillin-resistant Staphylococcus aureus
(MRSA).
Design: Single centred retrospective before and after
study design.
Setting: Launceston General Hospital, Tasmania,
Australia.
Participants: Patients with MRSA infection or
colonisation.
Interventions: Rooms occupied by patients with
MRSA infection or colonisation were cleaned following
discharge with either detergent or HP.
Main outcome measures: MRSA room
contamination following cleaning; new MRSA
acquisition in patients.
Results: Over 3600 discharge cleans were completed,
with more than 32 600 environmental swabs processed.
MRSA was isolated from 24.7% rooms following
detergent cleaning and from 18.8% of rooms after HP
(p<0.001). The incidence of MRSA acquisition reduced
from 9.0 to 5.3 per 10 000 patient days in detergent and
disinfectant arms, respectively (p<0.001).
Conclusions: Use of HP disinfection led to a decrease
in residual MRSA contamination in patient rooms
compared with detergent. It may also have encouraged
the reduction in patient MRSA acquisition despite
several confounders including staff feedback on
terminal cleaning, additional MRSA screening and
quicker laboratory methods. Infection control is best
served by concurrent interventions targeting both the
patient and healthcare environment.
INTRODUCTION
There is no single remedy for controlling
hospital-acquired infections (HAIs), although
current evidence supports a multifaceted
approach.1–3 Understanding the transmission
modes of infectious agents and applying basic
infection prevention and control principles
are critical for reducing HAIs.4 One
fundamental requirement for preventing
transmission in healthcare environments is
environmental cleanliness, since the environ-
ment serves as a reservoir for potential patho-
gens. Several studies have shown that if a
patient is admitted to a room previously occu-
pied by a patient colonised or infected with a
particular organism, presumed environmental
persistence increases the acquisition risk for
that patient with the same organism.5
Colonisation pressure is also thought to play a
role in the transmission of hospital organ-
isms.6–9 Additional studies have shown that
enhanced cleaning significantly decreases
environmental contamination of a range of
HAI pathogens.10–14 These studies, alongside
those evaluating colonisation pressure,
demonstrate the potential importance of the
environment in infection transmission and
prevention.15
Strengths and limitations of this study
▪ The large number of environmental swabs taken
over a long period is a key strength of this study.
▪ The ability to measure methicillin-resistant
Staphylococcus aureus (MRSA) contamination
and acquisition in a consistent manner over a
long period of time is also a strength.
▪ We were able to examine several potential con-
founders, not always possible when analysing
infection control interventions.
▪ Limitations include the two different processes
for application of HP disinfectant in the study,
since a vapourised disinfectant cannot be deliv-
ered in shared patient areas.
▪ Additional MRSA screening of inpatients was
initiated during the study and this could also
have had an effect on the overall outcome.
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Divergent opinions prevail as to whether surface disin-
fection is required for routine cleaning as opposed to
detergent cleaning.16 This translates into considerable
variations in practice, which complicates the overall
assessment of hospital cleaning methods. Controversy
over best practice and materials as well as the role of
cleaning itself as an important control intervention has
received recent comment.17–20 Thus, the impact of
surface disinfection versus detergent cleaning on HAI
rates remains scientifically unresolved, despite a growing
body of literature.19 21 This paper describes a study that
evaluated the efficacy of hydrogen peroxide (HP) decon-
tamination alongside patient monitoring and screening
against methicillin-resistant Staphylococcus aureus (MRSA)
HAI rates in an Australian hospital via a two-armed initia-
tive. MRSA was chosen as the target pathogen because
screening programmes for this organism are already well
established, and environmental persistence makes it
vulnerable to the cleaning process. MRSA is a reliable
indicator of overall hygiene practices in hospitals.14 22
METHODS
Study design
A retrospective before and after study design was used,
to assess the efficacy of HP decontamination versus use
of a detergent alone for terminal cleaning, with a focus
on MRSA patient acquisition and environmental load.
Setting
The study was conducted at Launceston General
Hospital, a 300-bed public hospital providing acute care
facilities for residents of Launceston and the northern
region of Tasmania, Australia. Every year the hospital
treats over 24 000 inpatients and 225 000 outpatients.
The hospital provides a range of treatments and services
including emergency care, intensive care, acute and
elective surgery and renal services. The study was con-
ducted between 1 January 2006 and 31 December 2012.
Interventions
Rooms accommodating MRSA patients were cleaned fol-
lowing discharge. Between 1 January 2006 and 30
October 2009, the rooms were cleaned twice with a pH
neutral detergent (mixed in warm water) and referred
to as the ‘detergent arm’ in this paper. From 1
November 2009, an initial clean using detergent was per-
formed, followed by the application of HP, herein
referred to as the ‘disinfectant arm’. In single rooms,
HP (6%) vapour decontamination was conducted using
the dry hydrogen vapour room decontamination system
(Nocospray, EquipMed, North Ryde, New South Wales,
Australia) according to the manufacturer’s instructions.
In shared rooms, HP was applied to surfaces using a
cloth, as per the manufacturer’s instructions. The
product used was Oxivir TB 0.5% (Diversey, Smithfield,
New South Wales, Australia). Both Nocospray and Oxivir
TB are registered with the Australian Therapeutic Goods
Administration as a hospital grade disinfectant. The
cleaning staff responsible for cleaning MRSA patient
rooms were provided with appropriate documented
training. Cleaning staff were in-house hospital employees
and not contractual staff.
Outcomes
The main outcomes for this study were identification of
MRSA from surfaces in the patient room following the
discharge clean, and the incidence of hospital-acquired
(HA) MRSA bacteraemia and HA MRSA acquisition
throughout the hospital for the period under study.
Identification of MRSA from patient rooms
Following a discharge clean, nine environmental swabs
were taken from each of the following sites: ceiling vent,
sink, console, bed, patient/visitor chair, patient table,
bedside locker, mattress and the pillow (following pillow-
case removal). The console is fixed to the wall behind
the patient’s bed and includes the oxygen supply and
patient call bell system. Swabs were taken by rolling a
swab, premoistened with sterile saline (0.9%), over the
designated surfaces and subsequently inoculated onto
MRSA agar plates (further details below). The same
environmental swabbing procedure was used throughout
the study period, and those persons responsible for
undertaking the environmental swabs remained constant
throughout the study.
Identification of patients with MRSA
An established patient screening programme identified
MRSA, whether colonised and/or infected. Persons
admitted to the hospital during the study period were
screened on admission for MRSA if they were nursing
home residents; interhospital transfers; or shared a
room with a person with known MRSA. Samples were
collected using a premoistened swab (with sterile saline)
from the nose, throat and perineum. From January
2010, all inpatients who remained in hospital also
received weekly MRSA screens. During 2010 and 2011,
compliance with admission and weekly MRSA screening
was monitored by reviewing all persons with MRSA
admitted to the hospital against laboratory testing under-
taken, with the hospital achieving 80% compliance or
higher. Infection control staff were notified of positive
MRSA results by the laboratory on a daily basis. The
results and patients were reviewed by infection control
staff. Patients with a laboratory result indicating MRSA
(screen or other specimen), with no history of MRSA
and negative admission screen were deemed to have
acquired MRSA. MRSA-positive patients were nursed
with contact precautions and either isolated in a single
room or placed in a room with other patients known to
have MRSA. Patients were not actively decolonised with
nasal creams and/or antiseptic body washes.
An episode of HA MRSA bacteraemia was defined as
an MRSA-positive blood culture, taken 48 h or longer
after admission. Only the first isolate per patient was
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counted, unless at least 14 days passed without add-
itional positive culture. Monthly numbers of HA MRSA
were collected in addition to the number of patient bed
days. The monthly incidence of HA MRSA per 10 000
patient care days was calculated. Monthly counts of
patients who acquired MRSA (colonisation and/or infec-
tion) during the study period were determined. The
monthly incidence of MRSA acquisition per 10 000
patient care days was subsequently calculated.
Microbiology laboratory methods
The microbiology laboratory performing relevant testing
during the study is an accredited laboratory (National
Association of Testing Authorities). In March 2009, the
laboratory changed from a mannitol salt and oxacillin
agar plate (PP2131 Oxoid Adelaide, South Australia,
Australia) to Brilliance chromogenic agar (Oxoid,
Adelaide, South Australia, Australia). Brilliance MRSA
Agar was directly inoculated from screening swabs. Plates
were allowed to warm to room temperature before inocu-
lation—for 20 h (minimum) at 37°C. Each plate was
divided into quarters to enable multiple swabs to be cul-
tured. This pragmatic approach was implemented in the
interests of cost, given the large number of swabs taken in
this study. The issue of potential cross-contamination
from multiple inoculations is in part reduced by the
primary data analysis undertaken, since we explored
whether any MRSA was present, rather than being site
specific. Additionally, one plate was used per patient or
room, so there would be no cross contamination.
Environmental and patient swabs were not inoculated
onto the same plates. The appearance of denim blue col-
onies suggested that MRSA and confirmatory tests were
performed, including antimicrobial susceptibilities.
Bias
We identified several potential confounders in evaluating
the effect of disinfectants on MRSA acquisition and room
contamination. Room contamination may be affected by
the competency of staff performing the clean, as well as
the efficacy of vapourised HP at penetrating different sur-
faces. To overcome these, the staff involved in the use of
HP were limited, received competency-based training
and were supervised by the researchers. An external
quality control process was also undertaken by the manu-
facturer. Rooms cleaned with vapourised HP were vali-
dated by using test strips specific to that product. The test
strips were used intermittently throughout the study to
identify any issues with application.
Acquisition of MRSA may be affected by hand hygiene
compliance and also by antimicrobial consumption.
Hand-hygiene compliance was monitored shortly after
the introduction of the HP intervention and then con-
tinued throughout, in accordance with a national
approach to hand-hygiene monitoring.23 Antimicrobial
consumption was recorded in order to identify changes
in antibiotic usage associated with MRSA, consistent with
national and international approaches.24
Data analysis
Data analysis was performed in SPPS V.20.0.25 The com-
parison between the presence or absence of MRSA in a
room for the two arms was undertaken using univariate
analysis. Fisher’s exact test (2 tail) was used to compare
the presence of MRSA in rooms following discharge
between the two arms. Time series analysis was subse-
quently applied to the data (also in SPPS V.20.0) with a
lag variable to allow for autocorrelation between
monthly measurements. The key variable of interest is
the change in cleaning approach. This analysis was
repeated for the overall proportion, and the propor-
tions, for each surface.
The comparison of MRSA bacteraemia and MRSA
acquisition between the two periods was performed
using Fisher’s exact test to determine any difference in
the total incidence between these two arms. To explore
this further, time series analysis was performed to
examine the monthly incidence of MRSA bacteraemia
and acquisition individually.
RESULTS
Environmental contamination
Three thousand six hundred and twenty-nine discharge
cleans were undertaken: 1917 in the detergent arm and
1712 in the disinfectant arm. There were 32 661 environ-
mental swabs processed during the entire study period.
Table 1 summarises MRSA detection from each environ-
mental site during the study period, for both the deter-
gent and disinfectant arms.
In rooms that were cleaned with a detergent, MRSA
was recovered from at least one site for 473 of 1917
(24.7%) rooms cleaned. This is a higher recovery rate
compared with 322 of 1712 (18.8%) rooms cleaned with
HP (p<0.001). Figure 1 illustrates the monthly propor-
tion of rooms that had MRSA identified from at least
one site during the study period. Of the 1712 rooms
cleaned with HP, 349 were manually cleaned with 0.5%
HP and 1363 with 6% vaporised HP using an automated
system.
Results for the overall proportion of rooms identified
with MRSA following a discharge clean were analysed
using time series (regression). Assessment of the resi-
duals of these models indicated no further serial correl-
ation or deviations from the assumptions of normality
and homogeneity. A significant positive autocorrelation
was found, suggesting that the level of MRSA in the pre-
vious month was indicative of the following month.
There was a small reduction in the overall proportion of
MRSA with the HP intervention, with a drop of 0.035 or
3.5% (95% CI 0.4% to −7.5%). This result was border-
line non-significant (p=0.08).
MRSA acquisition
The incidence of MRSA bacteraemia reduced from
0.16/10 000 patient care days (95% CI 0.04 to 0.35) in
the detergent arm to 0.11/10 000 patient care days
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(95% CI 0.02 to 0.30) in the HP arm. This reduction
was not significant (p=0.58). There was also a reduction
in the incidence of MRSA colonisation and infection
during the two arms, from 334 cases (9.0/10 000 patient
days) to 186 cases (5.3/10 000 patient days). This reduc-
tion was statistically significant (p<0.001) and was con-
firmed using time series analysis of the monthly
incidence of MRSA acquisition (p<0.001) (figure 2).
DISCUSSION
There are two main findings from this study. First, the
introduction of more stringent terminal cleaning using
HP led to a decrease in residual MRSA contamination in
patient rooms, compared with detergent alone (table 1;
figure 1). Second, following the introduction of HP,
there has been a reduction in the rate of new MRSA
patientacquisitions throughout the hospital. Both of
these findings will be discussed in detail.
The decrease in the number of rooms found to have
MRSA following a terminal clean with HP is
unsurprising given the antibacterial properties of this
agent. However, there are additional analyses to con-
sider. Univariate analysis compared the total proportion
of rooms found to have MRSA in each arm, demonstrat-
ing a significant reduction in MRSA. This method does
not account for changes over time, particularly if there
are confounders. Time series analysis is required to
address this point. The proportion of rooms found to
have MRSA each month were analysed over time and
the two arms compared. This showed a reduction in
MRSA contamination after terminal cleaning (p=0.08).
It is also worth noting that while there appears to be a
reduction after the intervention, there exists unex-
plained variability before the intervention, which contri-
butes to general uncertainty over the observed change
during the study period (figure 1).
Systematic screening showed that the bed was the only
item in the patient’s room where a significant reduction
in residual MRSA was found. Given that the majority of
rooms were cleaned with vapourised HP, a potential
Table 1 Univariate analysis comparing MRSA environmental contamination following cleaning with detergent and
disinfectant over a 6-year period in one 300 bed hospital
Detergent Disinfectant (HP)
Object No MRSA MRSA Per cent MRSA No MRSA MRSA Per cent MRSA p Value
Vent 1803 114 6.3 1622 90 5.5 0.39
Sink 1815 102 5.6 1640 72 4.4 0.12
Console 1799 118 6.6 1602 110 6.9 0.78
Bed 1703 214 12.6 1572 140 8.9 <0.01
Chair 1755 162 9.2 1565 147 9.4 0.90
Table 1761 156 8.9 1597 115 7.2 0.11
Locker 1786 131 7.3 1605 107 6.7 0.50
Mattress 1762 155 8.8 1604 108 6.7 0.04
Pillow 1824 93 5.1 1643 69 4.2 0.26
HP, hydrogen peroxide; MRSA, methicillin-resistant Staphylococcus aureus.
Figure 1 Presence of
methicillin-resistant
Staphylococcus aureus following
terminal cleaning, 2006–2012.
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explanation for this could be the positioning of the unit
in the room. There was little or no reduction in MRSA
contamination for the majority of screened items, so we
cannot be completely confident that HP was directly
associated with widespread reduction in MRSA contam-
ination. It is also important to note that the intervention
did not just involve the introduction of HP, but also
represented monitoring and feedback to the cleaning
and clinical staff. Environmental data were regularly
issued to staff and to the hospital executive. This process
also occurred during the detergent arm of the study.
The introduction of HP was led by the infection control
team, with a staff member in this team dedicated to over-
seeing its use. In addition, the number of people
responsible for discharge cleaning was reduced in the
disinfectant arm, making feedback more feasible. It is
possible that discussion of the methods and importance
of cleaning plus feedback all played an important part
in the improvements seen.26
This study also found a reduction in the amount of
new MRSA acquisitions in the hospital. As with all inter-
ventions of this nature, the impact of additional changes
other than cleaning over the study period cannot be
excluded. Potential confounders include enhanced
screening activity, change in laboratory methods and
antimicrobial consumption. At about the same time as
the introduction of HP decontamination, there was an
increase in admission and ongoing screening effort. All
inpatients who remained in hospital received weekly
MRSA screens in addition to more active admission
screening. It is possible that (1) more persons with
MRSA acquisition were identified following the introduc-
tion of weekly screens, and (2) additional admission and
ongoing screening, resulting in more patients, afforded
contact precautions. This should have reduced the
potential for cross transmission, but there was no
intervention other than contact precautions for newly
identified patients with MRSA.
Different laboratory methods for MRSA detection were
not thought to have had a significant impact on isolation
rates from either patients or the environment; both agar
types encourage growth of MRSA under standard labora-
tory conditions. However, use of chromogenic agar reduces
the time required to isolate MRSA from specimens, which
would speed up control interventions for positive patients
during this study. This may have had an impact on trans-
mission risk if patients were identified earlier than they
would have been with the original method.
Regarding antimicrobial consumption, data on fluoro-
quinolone and cephalosporin usage were as obtained
from the hospital’s pharmacy department from 1
January 2009 to 30 December 2011 for each month.
These were converted into the internationally recog-
nised drug usage rate daily defined doses (DDD)/1000
bed-days.24 While most antibiotics encourage MRSA
shedding and spread between patients, exposure to
these particular antibiotic classes are more likely to be
associated with increasing MRSA acquisition rates.27–29
Between 1 January 2009 and 30 October 2009, mean
DDDs of fluoroquinolone and cephalosporin agents
were 98.9 (95% CI 96.3 to 101.6) and 50.9 (95% CI 49.0
to 52.8) per 1000 bed-days, respectively. From 1
November 2009 until 31 December 2010, mean DDDs of
fluoroquinolone and cephalosporins were 67.6 (95% CI
66.6 to 68.8) and 56.3 (95% CI 55.1 to 57.6) per 1000
bed-days, respectively.30 There was therefore a significant
reduction in fluoroquinolone usage (p<0.001) alongside
a significant increase in cephalosporin use (p<0.001),
both of which may have affected the MRSA acquisition
rate during the study.
A further consideration is the impact of any changes
in hand hygiene compliance. Early in the study period
Figure 2 New
methicillin-resistant
Staphylococcus aureus
acquisitions, 2006–2012.
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(2009), a national hand hygiene initiative was intro-
duced in the hospital including monitoring of hand
hygiene compliance from early 2010, consistent with the
‘Five moments’ model.23 There was no statistical increase
in hand hygiene compliance when comparing data from
April 2010 to data at the end of 2012. Specifically, hand
hygiene compliance was 66.9% (95% CI 64.9% to
68.6%) in early 2010, compared with 70.4% (95% CI
68.3 to 72.5%) at the end of 2012.31 32 Further, a critical
element of the national hand hygiene programme, the
introduction of alcohol-based hand rub in patient care
areas, had already been in place since 2006.
STRENGTHS AND LIMITATIONS
The large number of environmental swabs, collected
over a long period of time in a systematic manner, is a
key strength of this paper. We are unaware of any other
study that has examined such a large number of envir-
onmental swabs when evaluating the use of a disinfect-
ant and detergent. A second strength of this study was
the ability to measure MRSA acquisition in a consistent
and robust manner, via admission and weekly patient
screening. Additionally, this study had the ability to
examine data on potential confounders, not always pos-
sible when analysing infection control interventions.
A limitation of this study is the use of two different
processes in the delivery of HP-vapour and application
by cloth. The reason for using these two processes was
due to the inability to release vapourised HP in shared
patient areas. In defence of this, we raise two points.
First, the aim of the study was to compare the use of a
detergent and disinfectant on MRSA contamination and
subsequent acquisition, not a comparison of different
applications of a disinfectant. This would be the logical
next step in future studies, exploring the most appropri-
ate methods for disinfectant use. Second, as MRSA
acquisition was examined at a hospital level, it would not
be possible to determine the relative effects of the two
methods used to apply HP.
Sufficient data were unavailable to evaluate the cost-
effectiveness of implementing HP in this study. The
introduction of HP in any hospital may have some add-
itional costs, potentially offset by increases in hospital
efficiency. Future studies evaluating the introduction of
a new cleaning intervention should consider whether
the intervention is cost-effective.
CONCLUSION
In conclusion, we assessed the efficacy of terminal HP
decontamination versus detergent alone by monitoring
the postclean environmental load alongside MRSA
patient acquisition. Introduction of disinfectant cleaning
led to a decrease in residual MRSA contamination in
patient rooms, compared with detergent. There was also
a reduction in the rate of new MRSA acquisitions
throughout the hospital. After considering potential
confounders, we propose that the reduction in the
MRSA acquisition rate was the result of several initiatives,
including disinfectant cleaning, focus on terminal clean-
ing (including staff feedback), additional MRSA screen-
ing, quicker laboratory methods and isolation. The
relative contribution of all of these is unknown.
Infection control is best served by concurrent interven-
tions targeting both the patient and healthcare
environment.
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